MedTrace Logo

Low Intensity Internet Therapy for Chronic Illness (@LIIT.CI)

NCT04408651 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2022-05-18

No results posted yet for this study

Summary

Chronic illness (CI) presents a significant and negative effect on quality of life and mental health. Further, emotion regulation has been considered of particular importance on the determination of chronic patients' well-being. Evidence suggests that Acceptance and Commitment Therapy (ACT) is an effective approach to improve psychological health in patients with CI. Further, there is some, although limited, evidence, that self-compassion training may be also useful in this context, and the inclusion of self-compassion elements in ACT interventions has even been the focus of attention by recent studies. Nevertheless, no study yet has compared the efficacy of these two types of intervention in CI. This is the aim of the present project - to analyse, in a low intensity eHealth intervention context, whether ACT or Compassion Focused Therapy (CFT) present superiority over the other in improving mental health and illness-related outcomes in CI.

Conditions

  • Chronic Medical Conditions

Interventions

BEHAVIORAL

LIIT.CI ACT

4-week online self-management intervention based on Acceptance and Commitment Therapy and adapted to people with chronic medical conditions

BEHAVIORAL

LIIT.CI CFT

4-week online self-management intervention based on Compassion-Focused Therapy and adapted to people with chronic medical conditions

Sponsors & Collaborators

  • University of Coimbra

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-12-31
Completion
2021-08-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04408651 on ClinicalTrials.gov